Matrix metalloproteinase gene expressions might be oxidative, stress targets in gastric cancer cell lines

Chinese Journal of Cancer Research

Volumn 25, Issue 3, 2013, Pages 322-333

  Gencer, Salih ^a,b   Cebeci, Anil ^c   Irmak Yazicioglu, Meliha Burcu ^c  

^a FATIH UNIVERSITY   (Turkey)

^b USKUDAR UNIVERSITY   (Turkey)

^c HALIC UNIVERSITY   (Turkey)

Author keywords

Caffeic acid phenethyl ester (CAPE); Expression; Hydrogen peroxide (H2O2); Matrix metalloproteinases (MMPs); Oxidative stress

Indexed keywords

BETA CATENIN; CAFFEIC ACID PHENETHYL ESTER; DICHLOROFLUORESCEIN; GELATINASE B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYDROGEN PEROXIDE; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 15; MATRIX METALLOPROTEINASE 17; MATRIX METALLOPROTEINASE 23; MATRIX METALLOPROTEINASE 28; MESSENGER RNA; STROMELYSIN; STROMELYSIN 2; STROMELYSIN 3; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL SHAPE; CELL VIABILITY; CYTOPLASM; GENE EXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH ADENOCARCINOMA;

EID: 84883798358     PISSN: 10009604     EISSN: 19930631     Source Type: Journal    
DOI: 10.3978/j.issn.1000-9604.2013.06.05     Document Type: Article

References (42)

1. Reuter S, Gupta SC, Chaturvedi MM, et al. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 2010;49:1603-16.
2. Cortes DF, Sha W, Hower V, et al. Differential gene expression in normal and transformed human mammary epithelial cells in response to oxidative stress. Free Radic Biol Med 2011;50:1565-74.
3. D'Autréaux B, Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 2007;8:813-24. (Pubitemid 47462134)
4. Morel Y, Barouki R. Repression of gene expression by oxidative stress. Biochem J 1999;342:481-96. (Pubitemid 29452631)
5. Dinkova-Kostova AT, Holtzclaw WD, Kensler TW. The role of Keap1 in cellular protective responses. Chem Res Toxicol 2005;18:1779-91. (Pubitemid 43023036)
6. Kobayashi M, Yamamoto M. Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid Redox Signal 2005;7:385-94. (Pubitemid 40279806)
7. Slupphaug G, Kavli B, Krokan HE. The interacting pathways for prevention and repair of oxidative DNA damage. Mutat Res 2003;531:231-51. (Pubitemid 37456735)
8. Clopton DA, Saltman P. Low-level oxidative stress causes cell-cycle specific arrest in cultured cells. Biochem Biophys Res Commun 1995;210:189-96.
9. Chua PJ, Yip GW, Bay BH. Cell cycle arrest induced by hydrogen peroxide is associated with modulation of oxidative stress related genes in breast cancer cells. Exp Biol Med (Maywood) 2009;234:1086-94.
10. Seng S, Avraham HK, Jiang S, et al. The nuclear matrix protein, NRP/B, enhances Nrf2-mediated oxidative stress responses in breast cancer cells. Cancer Res 2007;67:8596-604. (Pubitemid 47437435)
11. Almeida M, Han L, Martin-Millan M, et al. Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor- to forkhead box O-mediated transcription. J Biol Chem 2007;282:27298-305. (Pubitemid 47501978)
12. Hoogeboom D, Essers MA, Polderman PE, et al. Interaction of FOXO with beta -catenin inhibits beta- catenin/T cell factor activity. J Biol Chem 2008;283:9224-30.
13. Kaidi A, Williams AC, Paraskeva C. Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat Cell Biol 2007;9:210-7. (Pubitemid 46420864)
14. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003;3:276-85. (Pubitemid 37328863)
15. Sanders LM, Henderson CE, Hong MY, et al. Pro-oxidant environment of the colon compared to the small intestine may contribute to greater cancer susceptibility. Cancer Lett 2004;208:155-61.
16. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7. (Pubitemid 36019639)
17. Mantovani A. Cancer: Inflammation by remote control. Nature 2005;435:752-3. (Pubitemid 40839716)
18. Gialeli C, Theocharis AD, Karamanos NK. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 2011;278:16-27.
19. Farinati F, Cardin R, Cassaro M, et al. Helicobacter pylori, inflammation, oxidative damage and gastric cancer: a morphological, biological and molecular pathway. Eur J Cancer Prev 2008;17:195-200. (Pubitemid 351549658)
20. Sternlicht MD, Bissell MJ, Werb Z. The matrix metalloproteinase stromelysin -1 acts as a natural mammary tumor promoter. Oncogene 2000;19:1102-13. (Pubitemid 30153797)
21. McManus MT, Sharp PA. Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 2002;3:737-47.
22. Ito E, Yana I, Fujita C, et al. The role of MT2-MMP in cancer progression. Biochem Biophys Res Commun 2010;393:222-7.
23. Lowy AM, Clements WM, Bishop J, et al. beta-Catenin/ Wnt signaling regulates expression of the membrane type 3 matrix metalloproteinase in gastric cancer. Cancer Res 2006;66:4734-41.
24. Tang CH, Yamamoto A, Lin YT, et al. Involvement of matrix metalloproteinase-3 in CCL5/CCR5 pathway of chondrosarcomas metastasis. Biochem Pharmacol 2010;79:209-17.
25. Bass DA, Parce JW, Dechatelet LR, et al. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol 1983;130:1910-7. (Pubitemid 13091657)
26. Gencer S, Cebeci A, Irmak-Yazicioglu MB. Silencing of the MMP-3 gene by siRNA transfection in gastric cancer AGS cells. J Gastrointestin Liver Dis 2011;20:19-26.
27. 2 exposure. Turk J Gastroenterol 2011;22:145-51.
28. Wei H, Frenkel K. Suppression of tumor promoter-induced oxidative events and DNA damage in vivo by sarcophytol A: A possible mechanism of anti-promotion. Cancer Res 1992;52:2298-303.
29. Hattori-Nakakuki Y, Nishigori C, Okamoto K, et al. Formation of 8-hydroxy-2′-deoxyguanosine in epidermis of hairless mice exposed to near-UV. Biochem Biophys Res Commun 1994;201:1132-9.
30. Ohshima H, Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 1994;305: 253- 64.
31. Rosin MP, Saad el Din Zaki S, Ward AJ, et al. Involvement of inflammatory reactions and elevated cell proliferation in the development of bladder cancer in schistosomiasis patients. Mutat Res 1994;305:283-92.
32. Weitzman SA, Gordon LI. Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood 1990;76:655-63. (Pubitemid 20253278)
33. Ge X, Ma X, Meng J, et al. Role of Wnt-5A in interleukin-1 beta-induced matrix metalloproteinase expression in rabbit temporomandibular joint condylar chondrocytes. Arthritis Rheum 2009;60:2714-22.
34. Crawford HC, Fingleton BM, Rudolph-Owen LA, et al. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene 1999;18:2883-91. (Pubitemid 29250878)
35. Brabletz T, Jung A, Dag S, et al. beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 1999;155:1033-8. (Pubitemid 29488909)
36. Weiske J, Albring KF, Huber O. The tumor suppressor Fhit acts as a repressor of beta-catenin transcriptional activity. Proc Natl Acad Sci USA 2007;104:20344-9.
37. Mori K, Shibanuma M, Nose K. Invasive potential induced under long-term oxidative stress in mammary epithelial cells. Cancer Res 2004;64:7464-72. (Pubitemid 39372089)
38. Westermarck J, Kahari V. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 1999;13:781-92. (Pubitemid 29220691)
39. Rajagopalan S, Meng XP, Ramasamy S, et al. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 1996;98:2572-9. (Pubitemid 26415078)
40. Nelson KK, Melendez JA. Mitochondrial redox control of matrix metalloproteinases. Free Radic Biol Med 2004;37:768-84. (Pubitemid 39078549)
41. Yoon SO, Park SJ, Yoon SY, et al. Sustained production of H(2)O(2) activates pro-matrix metalloproteinase-2 through receptor tyrosine kinases/phosphatidylinositol 3-kinase/ NF-kappa B pathway. J Biol Chem 2002;277:30271-82.
42. Storz P. Reactive oxygen species in tumor progression. Front Biosci 2005;10:1881-96. (Pubitemid 40529044)